With ongoing research, its potential applications in treating sleep disorders, depression, and stress-related conditions make DSIP an exciting candidate in neuroregulatory studies (2)
It is a tripeptide molecule consisting of three amino acids cysteine, glycine, and glutamic acid
It may also interact with anti-arrhythmic drugs, such as propafenone and mexiletine, as well as anticoagulant medications
In conclusion, these results highlight the tolerability and therapeutic potential of TLC-2716 as a treatment for managing dyslipidemia and reducing residual atherosclerotic cardiovascular disease risk in humans
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG